search
Back to results

Video-assisted Thoracoscopic Surgery - Exparel Study

Primary Purpose

Pain, Postoperative

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Liposomal bupivacaine
Bupivacaine
Sponsored by
Rakesh Sondekoppam Vijayashankar
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative focused on measuring Video-assisted thoracoscopic surgery (VATS), Paravertebral blocks, Liposomal Bupivacaine (Exparel)

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age over 18 years and less than 80 years
  • Undergoing video-assisted thoracoscopic surgery (VATS) procedure
  • BMI less than 40

Exclusion Criteria:

  • Unable to provide informed consent
  • Non-English speaking
  • Pregnant
  • BMI greater than 40
  • Video-assisted thoracoscopic surgery pleurodesis subjects
  • Patients with pre-existing chronic pain
  • Opioid tolerance
  • Pain syndromes including fibromyalgia, regional pain syndrome or post therapeutic neuralgia in a thoracic distribution
  • Allergy to the study medication
  • Patients with infectious disease
  • Patients with impaired coagulation
  • Severe hepatic disease
  • Incarcerated

Sites / Locations

  • University of IowaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Liposomal bupivacaine

Bupivacaine

Arm Description

The patient will receive an intercostal nerve block by the surgeon in the operating room after anesthetic has been administered. The surgeon will use thoracoscopic guidance to administer the intercostal nerve block. The medication used in this block will liposomal bupivacaine (Exparel).

The patient will receive a paravertebral block by the anesthesiologist staffing the pain service area within the hospital prior to surgery. This regional anesthesia will be done using ultrasound guidance. The medication used in this block will be plain bupivacaine with epinephrine.

Outcomes

Primary Outcome Measures

Measure post-operative acute pain scores
Using a numerical rating scale (0-10), patients will be asked to report their pain level. The scale is from 0 to 10 with 0 being no pain and 10 representing the most intense pain.
Measure post-operative opioid usage
Review the subjects medical record to determine the type and amount of opioid medication that has been taken by the subject in the first 72 hours after surgery,

Secondary Outcome Measures

Measure lung function
Using an incentive spirometer device, the amount of air volume inhaled and exhaled by the lungs post VATS procedure. The subject will be asked to do 3 attempts in succession and the number recorded will be the average of the 3 attempts. The air volume inhaled is measured on a scale from near 0 to 2500 milliliters with the low number indicating little air movement whereas 2500 milliliters indicates good air flow. These results will be compared to the volume determined at baseline prior to surgery.
Measure post-operative opioid consumption following discharge from the hospital
Patients will be asked to keep a pain medication diary to record their use of opioid and non-opioid medications for pain control.
Measure post-operative pain scores after discharge from the hospital
Using a numerical rating scale, patients will be asked to report their pain level. The scale is from 0 to 10 with 0 being no pain and 10 representing the most intense pain. The goal for measuring after acute hospitalization is to determine if the patient is experiencing the onset of chronic pain.
Calculate length of hospital stay
Record the number of days the patients in both arms are hospitalized post VATS procedure. Compare these values between the two groups.
Record the return to normal bowel function
The patient will be asked to report when normal bowel function has returned. It will provide clinicians information as to when other body functions have returned following surgery.

Full Information

First Posted
February 22, 2021
Last Updated
September 19, 2023
Sponsor
Rakesh Sondekoppam Vijayashankar
Collaborators
American Society of Regional Anesthesia
search

1. Study Identification

Unique Protocol Identification Number
NCT04864210
Brief Title
Video-assisted Thoracoscopic Surgery - Exparel Study
Official Title
Analgesia for Video-assisted Thoracoscopic Surgeries: A Comparison Between Intercostal Blocks With Liposomal Bupivacaine and Paravertebral Blocks With Plain Bupivacaine
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 2, 2021 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
July 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Rakesh Sondekoppam Vijayashankar
Collaborators
American Society of Regional Anesthesia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Video-assisted thoracoscopic surgery (VATS) greatly decreased the number and types of surgery that required open thoracotomy. Initially it was thought that VATS would lead to a reduction of respiratory problems and less acute pain in patients when compared to patients receiving an open thoracic surgery. However, for reasons not clearly understood, a large number of patients who undergo VATS still experience moderate to severe post-surgical pain (1). Physicians are still faced with the challenge of providing care that will manage both the respiratory issues as well as manage acute pain. The goal of this study is to find the most suitable regimen to effectively manage post-VATS-related pain.
Detailed Description
The "promise" was that video-assisted thoracoscopic surgery (VATS) would be associated with less severe pulmonary impairment and less acute post-operative pain compared to open thoracotomy. However, VATS can cause moderate to severe post-operative pain in a significant number of patients and the reason for this is not well understood. In addition it has been found that post-surgical pain can be a strong predictor for the development of chronic pain. Inadequate control of acute pain not only causes serious discomfort and significant respiratory problems, but it may place this population of patients at greater risk of chronic pain and prescription opioid dependence. Current protocols to manage and/or reduce VATS associated pain include combining the use of regional anesthesia techniques with opioid and non-opioid analgesics. Recent studies have investigated the efficacy of intercostal blocks using liposomal bupivacaine after thoracic surgery. However, these studies lacked an active comparator population of patients. The study is designed as a prospective randomized study evaluating intercostal blocks using liposomal bupivacaine. The control population of patients will be treated with a paravertebral block using plain bupivacaine.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative
Keywords
Video-assisted thoracoscopic surgery (VATS), Paravertebral blocks, Liposomal Bupivacaine (Exparel)

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
128 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Liposomal bupivacaine
Arm Type
Experimental
Arm Description
The patient will receive an intercostal nerve block by the surgeon in the operating room after anesthetic has been administered. The surgeon will use thoracoscopic guidance to administer the intercostal nerve block. The medication used in this block will liposomal bupivacaine (Exparel).
Arm Title
Bupivacaine
Arm Type
Active Comparator
Arm Description
The patient will receive a paravertebral block by the anesthesiologist staffing the pain service area within the hospital prior to surgery. This regional anesthesia will be done using ultrasound guidance. The medication used in this block will be plain bupivacaine with epinephrine.
Intervention Type
Drug
Intervention Name(s)
Liposomal bupivacaine
Intervention Description
Surgeons will perform an intercostal nerve block in the operating room under thoracoscopic guidance while the patient is asleep under anesthesia. This intervention (block) is one of the standards of care but the medication (liposomal bupivacaine) currently is not FDA approved for this type of block.
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Intervention Description
An anesthesiologist trained in regional anesthesia will perform a paravertebral block in the hospital's pain service unit. This intervention is standard of care and will use plain bupivacaine with epinephrine as the medication
Primary Outcome Measure Information:
Title
Measure post-operative acute pain scores
Description
Using a numerical rating scale (0-10), patients will be asked to report their pain level. The scale is from 0 to 10 with 0 being no pain and 10 representing the most intense pain.
Time Frame
Up to 72 hours post procedure
Title
Measure post-operative opioid usage
Description
Review the subjects medical record to determine the type and amount of opioid medication that has been taken by the subject in the first 72 hours after surgery,
Time Frame
Up to 72 hours post procedure
Secondary Outcome Measure Information:
Title
Measure lung function
Description
Using an incentive spirometer device, the amount of air volume inhaled and exhaled by the lungs post VATS procedure. The subject will be asked to do 3 attempts in succession and the number recorded will be the average of the 3 attempts. The air volume inhaled is measured on a scale from near 0 to 2500 milliliters with the low number indicating little air movement whereas 2500 milliliters indicates good air flow. These results will be compared to the volume determined at baseline prior to surgery.
Time Frame
Up to 72 hours post procedure
Title
Measure post-operative opioid consumption following discharge from the hospital
Description
Patients will be asked to keep a pain medication diary to record their use of opioid and non-opioid medications for pain control.
Time Frame
Up to 6 months post procedure.
Title
Measure post-operative pain scores after discharge from the hospital
Description
Using a numerical rating scale, patients will be asked to report their pain level. The scale is from 0 to 10 with 0 being no pain and 10 representing the most intense pain. The goal for measuring after acute hospitalization is to determine if the patient is experiencing the onset of chronic pain.
Time Frame
Up to 6 months post procedure.
Title
Calculate length of hospital stay
Description
Record the number of days the patients in both arms are hospitalized post VATS procedure. Compare these values between the two groups.
Time Frame
Up to 7 days
Title
Record the return to normal bowel function
Description
The patient will be asked to report when normal bowel function has returned. It will provide clinicians information as to when other body functions have returned following surgery.
Time Frame
Up to 7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age over 18 years and less than 80 years Undergoing video-assisted thoracoscopic surgery (VATS) procedure BMI less than 40 Exclusion Criteria: Unable to provide informed consent Non-English speaking Pregnant BMI greater than 40 Video-assisted thoracoscopic surgery pleurodesis subjects Patients with pre-existing chronic pain Opioid tolerance Pain syndromes including fibromyalgia, regional pain syndrome or post therapeutic neuralgia in a thoracic distribution Allergy to the study medication Patients with infectious disease Patients with impaired coagulation Severe hepatic disease Incarcerated
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yatish Ranganath, MD
Phone
319-467-6798
Email
yatish-ranganath@uiowa.edu
First Name & Middle Initial & Last Name or Official Title & Degree
ZITA A SIBENALLER, PhD
Phone
319-356-8878
Email
zita-sibenaller@uiowa.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yatish Ranganath, MD
Organizational Affiliation
University of Iowa
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Iowa
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yatish Ranganath, MD
Phone
319-467-6798
Email
yatish-ranganath@uiowa.edu
First Name & Middle Initial & Last Name & Degree
ZITA A SIBENALLER
Phone
3193397429
Email
zsibenaller@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All of the individual participant data (IPD) collected during the trial, after deidentification will be shared with researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal. IPD will be available for sharing immediately after publication and ending 5 years following article publication.
IPD Sharing Time Frame
IPD will be available for sharing immediately after publication and ending 5 years following article publication.
IPD Sharing Access Criteria
IPD will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.
Citations:
PubMed Identifier
29878248
Citation
Bayman EO, Parekh KR, Keech J, Larson N, Vander Weg M, Brennan TJ. Preoperative Patient Expectations of Postoperative Pain Are Associated with Moderate to Severe Acute Pain After VATS. Pain Med. 2019 Mar 1;20(3):543-554. doi: 10.1093/pm/pny096.
Results Reference
background
PubMed Identifier
28248713
Citation
Bayman EO, Parekh KR, Keech J, Selte A, Brennan TJ. A Prospective Study of Chronic Pain after Thoracic Surgery. Anesthesiology. 2017 May;126(5):938-951. doi: 10.1097/ALN.0000000000001576.
Results Reference
background
PubMed Identifier
9262085
Citation
Furrer M, Rechsteiner R, Eigenmann V, Signer C, Althaus U, Ris HB. Thoracotomy and thoracoscopy: postoperative pulmonary function, pain and chest wall complaints. Eur J Cardiothorac Surg. 1997 Jul;12(1):82-7. doi: 10.1016/s1010-7940(97)00105-x.
Results Reference
background
PubMed Identifier
18632308
Citation
Steegers MA, Snik DM, Verhagen AF, van der Drift MA, Wilder-Smith OH. Only half of the chronic pain after thoracic surgery shows a neuropathic component. J Pain. 2008 Oct;9(10):955-61. doi: 10.1016/j.jpain.2008.05.009. Epub 2008 Jul 16.
Results Reference
background
PubMed Identifier
24288340
Citation
Steinthorsdottir KJ, Wildgaard L, Hansen HJ, Petersen RH, Wildgaard K. Regional analgesia for video-assisted thoracic surgery: a systematic review. Eur J Cardiothorac Surg. 2014 Jun;45(6):959-66. doi: 10.1093/ejcts/ezt525. Epub 2013 Nov 27.
Results Reference
background
PubMed Identifier
29416155
Citation
Adhikary SD, Pruett A, Forero M, Thiruvenkatarajan V. Erector spinae plane block as an alternative to epidural analgesia for post-operative analgesia following video-assisted thoracoscopic surgery: A case study and a literature review on the spread of local anaesthetic in the erector spinae plane. Indian J Anaesth. 2018 Jan;62(1):75-78. doi: 10.4103/ija.IJA_693_17.
Results Reference
background
PubMed Identifier
29199049
Citation
Shariat A, Bhatt H. Successful Use of Serratus Plane Block as Primary Anesthetic for Video-Assisted Thoracoscopic Surgery (VATS)-Assisted Pleural Effusion Drainage. J Cardiothorac Vasc Anesth. 2018 Feb;32(1):e31-e32. doi: 10.1053/j.jvca.2017.10.038. Epub 2017 Oct 31. No abstract available.
Results Reference
background
PubMed Identifier
26507422
Citation
Khalil KG, Boutrous ML, Irani AD, Miller CC 3rd, Pawelek TR, Estrera AL, Safi HJ. Operative Intercostal Nerve Blocks With Long-Acting Bupivacaine Liposome for Pain Control After Thoracotomy. Ann Thorac Surg. 2015 Dec;100(6):2013-8. doi: 10.1016/j.athoracsur.2015.08.017. Epub 2015 Oct 24.
Results Reference
background
PubMed Identifier
28329326
Citation
Parascandola SA, Ibanez J, Keir G, Anderson J, Plankey M, Flynn D, Cody C, De Marchi L, Margolis M, Blair Marshall M. Liposomal bupivacaine versus bupivacaine/epinephrine after video-assisted thoracoscopic wedge resectiondagger. Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):925-930. doi: 10.1093/icvts/ivx044.
Results Reference
background
PubMed Identifier
25912739
Citation
Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia. Ann Thorac Surg. 2015 Jun;99(6):1953-60. doi: 10.1016/j.athoracsur.2015.02.074. Epub 2015 Apr 23.
Results Reference
background
Links:
URL
https://www.medpagetoday.com/anesthesiology/anesthesiology/71224
Description
"FDA Advisors Skeptical of Liposomal Bupivacaine for Regional Pain Control"

Learn more about this trial

Video-assisted Thoracoscopic Surgery - Exparel Study

We'll reach out to this number within 24 hrs